Videos Library
The impact of PROs on HTA decision-making
Related topics:
Pharmaceutical/Biotech, Europe, Market Access & HEOR
Overview
- Current perception of PRO evidence among payers and its influence in decision-making
- Differences between payer and regulators in assessing PRO evidence
Speaker
Anke van Engen
Principal, Consulting Services
QuintilesIMS
Photo
Subscribe or unlock this video to download the presentation slides. If you already have an account, please log in.
REMINDER
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.
Sponsor
